These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2895828)

  • 1. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine.
    Robertson SE; Traverso HP; Drucker JA; Rovira EZ; Fabre-Teste B; Sow A; N'Diaye M; Sy MT; Diouf F
    Lancet; 1988 Apr; 1(8591):897-9. PubMed ID: 2895828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.
    Simoes EA; John TJ
    J Biol Stand; 1986 Apr; 14(2):127-31. PubMed ID: 3020057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to measles vaccine with DTPP.
    John TJ; Selvakumar R; Balrai V; Simoes EA
    Am J Dis Child; 1987 Jan; 141(1):14. PubMed ID: 3491536
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV).
    Knuf M; Vetter V; Celzo F; Ramakrishnan G; Van Der Meeren O; Jacquet JM
    Hum Vaccin; 2010 Jul; 6(7):554-61. PubMed ID: 20448468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
    Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
    Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
    Rümke HC
    Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccine policy likely to be reassessed in 1990s when polio-DTP combination becomes available.
    Marwick C
    JAMA; 1988 Jun; 259(24):3523-4. PubMed ID: 3259637
    [No Abstract]   [Full Text] [Related]  

  • 13. Poliovirus vaccine policy. Another perspective.
    Katz SL
    Am J Dis Child; 1989 Sep; 143(9):1007-9. PubMed ID: 2788992
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of immunogenicity of combined DPT--inactivated injectable polio vaccine (DPT - IPV) and association of DPT and attenuated oral polio vaccine (DPT + OPV) in Pakistani children.
    Qureshi AW; Zulfiqar I; Raza A; Siddiqi N
    J Pak Med Assoc; 1989 Feb; 39(2):31-5. PubMed ID: 2499700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tetravalent diphtheria, tetanus, pertussis and inactivated poliomyelitis vaccine].
    Fillastre C; Brégère P; Guérin N
    Arch Fr Pediatr; 1989 Nov; 46(9):693-700. PubMed ID: 2604532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a combined DTP-polio vaccine in a reduced schedule.
    Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N
    Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new combined inactivated DPT-polio vaccine.
    Drucker J; Soula G; Diallo O; Fabre P
    Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IPAD-DTCP: study of the tolerability and serum antipoliomyelitic efficacy in a maternal-child health center at Pikine (Dakar)].
    Loucq C; Yvonnet B; Jeannee E; Marie FN; Chabanier G
    Med Trop (Mars); 1984; 44(1):65-7. PubMed ID: 6330491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries.
    Cohen H; Nagel J
    Rev Infect Dis; 1984; 6 Suppl 2():S350-1. PubMed ID: 6610910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.